Gene Therapy

Gene Therapy

Fixing the sickle cell disease gene London – Jan 2022 Sickle cell disease (SCD) is a genetic disorder caused by a mutation in both copies of a person’s HBB gene. This gene encodes a component of haemoglobin, the oxygen-carrying protein in red blood cells. The...
Letter from the Trustees

Letter from the Trustees

Progress Against Our Social Business Strategy Ibadan – Dec 2021   Letter from the Trustees Dear Donors & Partners, As the calendar year draws to a close and the festive period gets underway, we hope you will have the opportunity to connect and spend...
Amoke Delivers Ahead of Santa

Amoke Delivers Ahead of Santa

Medical Equipment & Supplies Donated to Partners Ibadan – Dec 2021 Amoke Foundation has fulfilled one of its promises less than six months after the official launch of the charitable organisation. In collaboration with its partner,  Medshare – an...
Amoke – in the news!

Amoke – in the news!

Sickle cell and laudable interventions Punch – Tola Dehinde  6th Nov 2021 A few months ago, a friend sent me an invitation to the launch of a foundation dedicated to sickle cell. I do get a lot of such invites, especially as we are in the Zoom era.  Sometimes,...
Crizanlizumab

Crizanlizumab

NHS England to offer breakthrough treatment for sickle cell disease The Guardian – Andrew Gregory (Health Editor) Oct 5, 2021 Crizanlizumab is the first new therapy for 20 years for serious and lifelong health condition Thousands of patients in England are to...
Donate